These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30059794)

  • 41. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment.
    Braun P; Greenberg D; Dasberg H; Lerer B
    J Clin Psychiatry; 1990 Jun; 51(6):236-8. PubMed ID: 2189869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BusWorld: an analog pilot test of a virtual environment designed to treat posttraumatic stress disorder originating from a terrorist suicide bomb attack.
    Josman N; Reisberg A; Weiss PL; Garcia-Palacios A; Hoffman HG
    Cyberpsychol Behav; 2008 Dec; 11(6):775-7. PubMed ID: 18991534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer.
    Difede J; Rothbaum BO; Rizzo AA; Wyka K; Spielman L; Reist C; Roy MJ; Jovanovic T; Norrholm SD; Cukor J; Olden M; Glatt CE; Lee FS
    Transl Psychiatry; 2022 Jul; 12(1):299. PubMed ID: 35896533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D-cycloserine enhances generalization of fear extinction in children.
    Byrne SP; Rapee RM; Richardson R; Malhi GS; Jones M; Hudson JL
    Depress Anxiety; 2015 Jun; 32(6):408-14. PubMed ID: 25775435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.
    Levinson CA; Rodebaugh TL; Fewell L; Kass AE; Riley EN; Stark L; McCallum K; Lenze EJ
    J Clin Psychiatry; 2015 Jun; 76(6):e787-93. PubMed ID: 26132687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virtual reality exposure therapy for PTSD Vietnam Veterans: a case study.
    Rothbaum BO; Hodges L; Alarcon R; Ready D; Shahar F; Graap K; Pair J; Hebert P; Gotz D; Wills B; Baltzell D
    J Trauma Stress; 1999 Apr; 12(2):263-71. PubMed ID: 10378165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.
    Mataix-Cols D; Turner C; Monzani B; Isomura K; Murphy C; Krebs G; Heyman I
    Br J Psychiatry; 2014 Jan; 204(1):77-8. PubMed ID: 24262813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancing Extinction Learning in Posttraumatic Stress Disorder With Brief Daily Imaginal Exposure and Methylene Blue: A Randomized Controlled Trial.
    Zoellner LA; Telch M; Foa EB; Farach FJ; McLean CP; Gallop R; Bluett EJ; Cobb A; Gonzalez-Lima F
    J Clin Psychiatry; 2017 Jul; 78(7):e782-e789. PubMed ID: 28686823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The psychophysiological response during post-traumatic stress disorder treatment with modular motion-assisted memory desensitisation and reconsolidation (3MDR).
    van Deursen R; Jones K; Kitchiner N; Hannigan B; Barawi K; Bisson JI
    Eur J Psychotraumatol; 2021 Jun; 12(1):1929027. PubMed ID: 34221251
    [No Abstract]   [Full Text] [Related]  

  • 52. Skin Conductance Reactivity to Standardized Virtual Reality Combat Scenes in Veterans with PTSD.
    van 't Wout M; Spofford CM; Unger WS; Sevin EB; Shea MT
    Appl Psychophysiol Biofeedback; 2017 Sep; 42(3):209-221. PubMed ID: 28646388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychological trauma symptom improvement in veterans using emotional freedom techniques: a randomized controlled trial.
    Church D; Hawk C; Brooks AJ; Toukolehto O; Wren M; Dinter I; Stein P
    J Nerv Ment Dis; 2013 Feb; 201(2):153-60. PubMed ID: 23364126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Transcendental Meditation Program's Impact on the Symptoms of Post-traumatic Stress Disorder of Veterans: An Uncontrolled Pilot Study.
    Herron RE; Rees B
    Mil Med; 2018 Jan; 183(1-2):e144-e150. PubMed ID: 29401353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.
    Flanagan JC; Sippel LM; Wahlquist A; Moran-Santa Maria MM; Back SE
    J Psychiatr Res; 2018 Mar; 98():64-69. PubMed ID: 29294429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repeated trauma exposure does not impair distress reduction during imaginal exposure for posttraumatic stress disorder.
    Jerud AB; Farach FJ; Bedard-Gilligan M; Smith H; Zoellner LA; Feeny NC
    Depress Anxiety; 2017 Aug; 34(8):671-678. PubMed ID: 27921349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders.
    Rapee RM; Jones MP; Hudson JL; Malhi GS; Lyneham HJ; Schneider SC
    Behav Res Ther; 2016 Dec; 87():225-231. PubMed ID: 27771572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Smits JA; Broekman TG; van Minnen A
    J Psychiatr Res; 2014 Jan; 48(1):40-6. PubMed ID: 24183818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conditioned fear and extinction learning performance and its association with psychiatric symptoms in active duty Marines.
    Acheson DT; Geyer MA; Baker DG; Nievergelt CM; Yurgil K; Risbrough VB;
    Psychoneuroendocrinology; 2015 Jan; 51():495-505. PubMed ID: 25444643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of military motion-assisted memory desensitization and reprocessing treatment on the symptoms of combat-related post traumatic stress disorder: first preliminary results.
    Vermetten E; Meijer L; van der Wurff P; Mert A
    Stud Health Technol Inform; 2013; 191():125-7. PubMed ID: 23792857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.